In utero as a potential location for cell transplantation

Mark A. Suckow, Elliot Rosen

Research output: Contribution to journalArticle

Abstract

A variety of diseases, including some which affect the hemostatic and blood coagulation systems, result from dysfunction of specific cell types. Attempts to ameliorate such diseases by implantation of healthy donor cells typically fail due to immune rejection of the donor cells. One method to possibly overcome this limitation is to administer donor cells prior to immune competence, thus inducing immune tolerance to the donated cells. To accomplish this, donor cells must be administered in utero, relatively early in the developmental process. We describe herein studies in which engraftments of fetal hepatocytes and a hepatoblast line were successfully accomplished by in utero administration of cells in mice. This approach reversed the clinical outcome of Factor X (FX) deficiency, increasing the survival time of FX null mice. Further, engraftment of donor cells was observed in the liver, as well as the spleen, brain, interstitium of the gonad, and lung. These results demonstrate the potential for application of in utero administration of fetal or blast cells for correction of disease related to specific cell or tissue dysfunction. The potential for ectopic engraftment suggests that this approach requires further refinement.

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalJournal of Organ Dysfunction
Volume3
Issue number3
DOIs
StatePublished - 2007

Fingerprint

Cell Transplantation
Factor X Deficiency
Factor X
Immune Tolerance
Gonads
Blood Coagulation
Hemostatics
Mental Competency
Hepatocytes
Spleen
Lung
Liver

Keywords

  • Cell transplantation
  • Factor X deficiency
  • Hepatocyte
  • In utero

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Critical Care
  • Physiology
  • Molecular Biology

Cite this

In utero as a potential location for cell transplantation. / Suckow, Mark A.; Rosen, Elliot.

In: Journal of Organ Dysfunction, Vol. 3, No. 3, 2007, p. 143-149.

Research output: Contribution to journalArticle

@article{c918fc0d7f7f492f9fd4790a6489aeca,
title = "In utero as a potential location for cell transplantation",
abstract = "A variety of diseases, including some which affect the hemostatic and blood coagulation systems, result from dysfunction of specific cell types. Attempts to ameliorate such diseases by implantation of healthy donor cells typically fail due to immune rejection of the donor cells. One method to possibly overcome this limitation is to administer donor cells prior to immune competence, thus inducing immune tolerance to the donated cells. To accomplish this, donor cells must be administered in utero, relatively early in the developmental process. We describe herein studies in which engraftments of fetal hepatocytes and a hepatoblast line were successfully accomplished by in utero administration of cells in mice. This approach reversed the clinical outcome of Factor X (FX) deficiency, increasing the survival time of FX null mice. Further, engraftment of donor cells was observed in the liver, as well as the spleen, brain, interstitium of the gonad, and lung. These results demonstrate the potential for application of in utero administration of fetal or blast cells for correction of disease related to specific cell or tissue dysfunction. The potential for ectopic engraftment suggests that this approach requires further refinement.",
keywords = "Cell transplantation, Factor X deficiency, Hepatocyte, In utero",
author = "Suckow, {Mark A.} and Elliot Rosen",
year = "2007",
doi = "10.1080/17471060601137464",
language = "English",
volume = "3",
pages = "143--149",
journal = "Journal of Organ Dysfunction",
issn = "1747-1060",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - In utero as a potential location for cell transplantation

AU - Suckow, Mark A.

AU - Rosen, Elliot

PY - 2007

Y1 - 2007

N2 - A variety of diseases, including some which affect the hemostatic and blood coagulation systems, result from dysfunction of specific cell types. Attempts to ameliorate such diseases by implantation of healthy donor cells typically fail due to immune rejection of the donor cells. One method to possibly overcome this limitation is to administer donor cells prior to immune competence, thus inducing immune tolerance to the donated cells. To accomplish this, donor cells must be administered in utero, relatively early in the developmental process. We describe herein studies in which engraftments of fetal hepatocytes and a hepatoblast line were successfully accomplished by in utero administration of cells in mice. This approach reversed the clinical outcome of Factor X (FX) deficiency, increasing the survival time of FX null mice. Further, engraftment of donor cells was observed in the liver, as well as the spleen, brain, interstitium of the gonad, and lung. These results demonstrate the potential for application of in utero administration of fetal or blast cells for correction of disease related to specific cell or tissue dysfunction. The potential for ectopic engraftment suggests that this approach requires further refinement.

AB - A variety of diseases, including some which affect the hemostatic and blood coagulation systems, result from dysfunction of specific cell types. Attempts to ameliorate such diseases by implantation of healthy donor cells typically fail due to immune rejection of the donor cells. One method to possibly overcome this limitation is to administer donor cells prior to immune competence, thus inducing immune tolerance to the donated cells. To accomplish this, donor cells must be administered in utero, relatively early in the developmental process. We describe herein studies in which engraftments of fetal hepatocytes and a hepatoblast line were successfully accomplished by in utero administration of cells in mice. This approach reversed the clinical outcome of Factor X (FX) deficiency, increasing the survival time of FX null mice. Further, engraftment of donor cells was observed in the liver, as well as the spleen, brain, interstitium of the gonad, and lung. These results demonstrate the potential for application of in utero administration of fetal or blast cells for correction of disease related to specific cell or tissue dysfunction. The potential for ectopic engraftment suggests that this approach requires further refinement.

KW - Cell transplantation

KW - Factor X deficiency

KW - Hepatocyte

KW - In utero

UR - http://www.scopus.com/inward/record.url?scp=34848920844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848920844&partnerID=8YFLogxK

U2 - 10.1080/17471060601137464

DO - 10.1080/17471060601137464

M3 - Article

AN - SCOPUS:34848920844

VL - 3

SP - 143

EP - 149

JO - Journal of Organ Dysfunction

JF - Journal of Organ Dysfunction

SN - 1747-1060

IS - 3

ER -